# EDGAR Filing Document

**Accession Number:** 0001313938
**File Stem:** 0001683168-23-001010
**Filing Date:** 2023-2
**Character Count:** 2723
**Document Hash:** f56807cbc482b40f7ec6de394f12e811
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-23-001010.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0001683168-23-001010

**CONFORMED SUBMISSION TYPE**: 1-A-W

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sibannac, Inc.
- **CENTRAL INDEX KEY:** 0001313938
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 330903494
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** 1-A-W
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-11780
- **FILM NUMBER:** 23639800

**BUSINESS ADDRESS:**
- **STREET 1:** 2122 E. HIGHLAND AVENUE, SUITE 425
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85016
- **BUSINESS PHONE:** 480-498-8300

**MAIL ADDRESS:**
- **STREET 1:** 2122 E. HIGHLAND AVENUE, SUITE 425
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sibannic, Inc.
- **DATE OF NAME CHANGE:** 20150310

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Naprodis, Inc.
- **DATE OF NAME CHANGE:** 20050110

**Sibannac, Inc.**

9535 E. Doubletree Ranch Rd., Ste 120

Scottsdale, AZ 85032

**Phone:** (480) 407-6445

Michael Davis

Division of Corporation Finance

Office of Life Sciences

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Sibannac, Inc.** |
|  | **Form 1A/A Amendment Withdrawal** |
|  | **Regulation A Offering Statement on Form 1-A** |
|  | **File No. 024-11780** |

---

**February 16, 2023**

**Dear Mr. Davis,** 

**This letter sets forth the request of Sibannac, Inc., ("SNNC" or the "Company") for the Withdrawal of its Form 1-A Amendment to its Regulation A Offering on Form 1-A/A.** 

Sibannac, Inc., (Applicant) pursuant to Rule 259 of Regulation A and via this 1-AW filing, hereby applies for the Commission's consent to withdraw its Form 1-A/A Offering Statement dated February 15, 2023, file number 024-111780.

The Offering Statement was submitted as a Form 1-A/A instead of as a new Form 1-A. The correct Offering Statement will be resubmitted under Form 1-A. The Company also affirms that no securities were sold under the Form 1-A Amendment on Form 1-A/A filing.

We trust the foregoing is in order.

 

If you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (480) 407-6445 or Carl Ranno, Esq. at (602) 493-0369. Thank you for your attention to this matter.

---

| |
|:---|
| **Sibannac, Inc.** |
| *<u>/s/David Mersky</u>* |
| Name: David Mersky |
| Title: Chief Executive Officer, Director |

---